“We want to ‘Heal The World’ through our scientific evidence-based Ayurveda”
New research conducted by Dr Rohit Sane at Madhavbaug in Bengaluru, India, has revealed that Ayurveda treatments and therapies can reduce various cardio-metabolic risk factors. The study also found that the hospitalisation time was shorter, and the long-term survival rate longer among heart patients who sought Ayurveda remedies, compared to patients who took allopathic treatment. Madhavbaug is an Ayurveda clinic that specialises in treating and reversing cardio-metabolic disorders.
The study was done over a period of three years on 572 patients with various comorbidities, including chronic heart failure, post-myocardial infarction, post percutaneous transluminal coronary angioplasty, hypertension, obesity, arthritis and diabetes. The research study was accepted for publication by the Annals Of Clinical Cardiology.
Dr Rohit Sane, the founder of Madhavbaug, explained the findings of the study at the 9th World Ayurveda Congress (WAC) held in Panjim, Goa.
“Heart patients who took 21 Panchakarma therapies and followed a strict diet high in antioxidants for three months, coupled with mild exercises like Pranayama and meditation, showed a significant improvement in lipid profile and an average 29% reduction in longitudinal plaque in their arteries. India’s Prime Minister Narendra Modi visits the Madhavbaug exhibition in December 2022
“Our ancient healing science is under-utilised in terms of conquering the growing mortality and hospitalisation due to coronary artery disease. Our clinical studies showed that non-invasive and low cost Ayurveda remedies are effective in combating cardiac ailments. We want to make Ayurveda a standard treatment for cardiac ailments,” explained Dr Rohit Sane.